SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,307,660 | -73.3% | 464,559 | -61.8% | 0.00% | -66.7% |
| Q2 2023 | $12,393,139 | +82509.9% | 1,216,206 | -26.5% | 0.01% | -33.3% |
| Q1 2023 | $15,002 | +153.4% | 1,654,013 | +100.3% | 0.01% | +200.0% |
| Q4 2022 | $5,920 | -96.4% | 825,725 | +3161.5% | 0.00% | – |
| Q3 2022 | $165,000 | -5.7% | 25,317 | -30.1% | 0.00% | – |
| Q2 2022 | $175,000 | +24.1% | 36,216 | +46.2% | 0.00% | – |
| Q1 2022 | $141,000 | -15.6% | 24,771 | -25.7% | 0.00% | – |
| Q4 2021 | $167,000 | -25.1% | 33,338 | -0.6% | 0.00% | – |
| Q3 2021 | $223,000 | -36.8% | 33,542 | -41.9% | 0.00% | – |
| Q2 2021 | $353,000 | +36.3% | 57,717 | +64.6% | 0.00% | -100.0% |
| Q1 2020 | $259,000 | +139.8% | 35,059 | +3.8% | 0.00% | – |
| Q2 2019 | $108,000 | -0.9% | 33,780 | +75.0% | 0.00% | – |
| Q2 2018 | $109,000 | -76.4% | 19,300 | -49.5% | 0.00% | -100.0% |
| Q4 2017 | $462,000 | – | 38,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |